Hwang Yusun, Huh Jung Won, Mun Yeung Chul, Seong Chu Myong, Chung Wha Soon
Department of Laboratory Medicine, Division of Hematology-Oncology, Ewha Womans University School of Medicine, Seoul, Korea.
Korean J Lab Med. 2010 Apr;30(2):105-10. doi: 10.3343/kjlm.2010.30.2.105.
In patients with isolated thrombocytopenia, but without significant dysplasia, diagnosis of idiopathic thrombocytopenic purpura (ITP) rather than myelodysplastic syndrome (MDS) may be taken into account. It is important to make an accurate diagnosis because different treatments are used for ITP and MDS. The purpose of this study was to investigate the clinical and hematologic features of patients who were initially diagnosed as ITP but had cytogenetic abnormalities.
We retrospectively reviewed cytogenetic studies of 100 patients who were diagnosed as ITP from 2004 to 2009 at Mokdong Hospital of Ewha Womans University based on clinical features and hematologic studies. Bone marrow pathology was re-evaluated based on 2008 WHO classification. Cytogenetic analysis was performed by 24-48 hr culture of bone marrow aspirates without using mitogens and 20 metaphases were analyzed.
Of the 100 patients diagnosed as ITP initially, three patients (3%) had cytogenetic abnormalities. They had no thrombocytopenia-related symptoms and thrombocytopenia was found accidentally. The numbers of megakaryocytes in bone marrow were increased and dysplasia was not found in megakaryocyte, erythroid, and myeloid cell lineages. The proportion of blasts was within normal limits. Clonal chromosomal abnormalities found were der(1;7)(q10;p10), add(9)(q12), or t(7;11)(p22;q12). Presumptive diagnosis of MDS or diagnosis of idiopathic cytopenia of undetermined significance (ICUS) was made according to 2008 WHO classification. During the follow up, disease progression was not found.
In patients with suspected ITP, cytogenetic analysis should be done. If specific clonal chromosomal abnormality is found, presumptive diagnosis of MDS has to be considered and close follow up is needed.
在孤立性血小板减少但无明显发育异常的患者中,可考虑诊断为特发性血小板减少性紫癜(ITP)而非骨髓增生异常综合征(MDS)。准确诊断很重要,因为ITP和MDS采用不同的治疗方法。本研究的目的是调查最初诊断为ITP但存在细胞遗传学异常的患者的临床和血液学特征。
我们回顾性分析了2004年至2009年在梨花女子大学木洞医院根据临床特征和血液学检查诊断为ITP的100例患者的细胞遗传学研究。根据2008年世界卫生组织(WHO)分类对骨髓病理学进行重新评估。通过对未使用促有丝分裂原的骨髓抽吸物进行24 - 48小时培养进行细胞遗传学分析,并分析20个中期分裂相。
在最初诊断为ITP的100例患者中,3例(3%)存在细胞遗传学异常。他们没有血小板减少相关症状,血小板减少是偶然发现的。骨髓中巨核细胞数量增加,巨核细胞、红系和髓系细胞系均未发现发育异常。原始细胞比例在正常范围内。发现的克隆性染色体异常为der(1;7)(q10;p10)、add(9)(q12)或t(7;11)(p22;q12)。根据2008年WHO分类做出MDS的初步诊断或意义未明的特发性血细胞减少症(ICUS)的诊断。在随访期间,未发现疾病进展。
对于疑似ITP的患者,应进行细胞遗传学分析。如果发现特定的克隆性染色体异常,必须考虑MDS的初步诊断并需要密切随访。